Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16126918rdf:typepubmed:Citationlld:pubmed
pubmed-article:16126918lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:16126918lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:16126918lifeskim:mentionsumls-concept:C0009924lld:lifeskim
pubmed-article:16126918lifeskim:mentionsumls-concept:C0282461lld:lifeskim
pubmed-article:16126918lifeskim:mentionsumls-concept:C0041703lld:lifeskim
pubmed-article:16126918pubmed:issue1lld:pubmed
pubmed-article:16126918pubmed:dateCreated2005-9-26lld:pubmed
pubmed-article:16126918pubmed:abstractTextTo assess prospectively the efficacy and safety of postcontrast magnetic resonance (MR) imaging with gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) compared with that of precontrast MR imaging in patients who are known to have or are suspected of having liver lesions and who are scheduled for hepatic surgery.lld:pubmed
pubmed-article:16126918pubmed:languageenglld:pubmed
pubmed-article:16126918pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16126918pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16126918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16126918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16126918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16126918pubmed:statusMEDLINElld:pubmed
pubmed-article:16126918pubmed:monthOctlld:pubmed
pubmed-article:16126918pubmed:issn0033-8419lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:SiegelmanEvan...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:SchwartzLawre...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:PaulsonErik...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:LeeFred TFTJrlld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:SahaniDushyan...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:FrancisIsaac...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:LuDavidDlld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:BluemkeDavid...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:KrinskyGlennGlld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:CasalinoDavid...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:BrownJeffrey...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:WeberTherese...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:BalzerThomasTlld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:WelberAdamAlld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:ShamsiKohkanKlld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:DavisPeter...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:BreuerJosyJlld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:SmallWilliam...lld:pubmed
pubmed-article:16126918pubmed:authorpubmed-author:AmendolaMarco...lld:pubmed
pubmed-article:16126918pubmed:copyrightInfoRSNA, 2005lld:pubmed
pubmed-article:16126918pubmed:issnTypePrintlld:pubmed
pubmed-article:16126918pubmed:volume237lld:pubmed
pubmed-article:16126918pubmed:ownerNLMlld:pubmed
pubmed-article:16126918pubmed:authorsCompleteYlld:pubmed
pubmed-article:16126918pubmed:pagination89-98lld:pubmed
pubmed-article:16126918pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:meshHeadingpubmed-meshheading:16126918...lld:pubmed
pubmed-article:16126918pubmed:year2005lld:pubmed
pubmed-article:16126918pubmed:articleTitleEfficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.lld:pubmed
pubmed-article:16126918pubmed:affiliationJohns Hopkins University School of Medicine, 600 N Wolfe St, Baltimore, MD 21287, USA.lld:pubmed
pubmed-article:16126918pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16126918pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16126918pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16126918lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16126918lld:pubmed